News

Qilu's Projects of Pemetrexed Disodium and Risperidone are appraised by Shandong Science & Technology

ABOUT US

News

Qilu's Projects of Pemetrexed Disodium and Risperidone are appraised by Shandong Science & Technology

Release time：

2009-12-24

Recently, an appraising meeting was held by Department of Science & Technology of Shandong. The technical data of Qilu's Projects, i.e. Pemetrexed disodium and Risperidone, were reviewed and appraised by the experts on the meeting. Pemetrexed disodium and Risperidone are newly launched products by Qilu, and have created good social and economic benefits.

After the careful study, all the experts agreed that the manufacturing process of the aforesaid products have reached the most advanced level in the world. The high appraisement does not only demonstrate the R&D capability of Qilu, but also creates favorable conditions for Qilu's future sales and marketing.

Qilu Pharma got CEP for Ondansetron HCl

President Li Botao ranks among 60 Figures in 60-year

Related News

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list

2022-07-18

The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

2022-06-15

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company